Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial
Explore this paper's citation graph
Summary
A post hoc analysis of the phase 2b randomized clinical single-masked multicenter noninferiority Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy found that NVD is less frequent but is associated with more resistance to currently available treatments than NVE.
- Published
- 2021-01-01
- Cited by
- 3
- References
- 16
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:261805985
References
- Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
- Retinal Vascular Calibre, Geometry and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
- Posterior ciliary artery circulation in health and disease: the Weisenfeld lecture.
- Proliferative diabetic retinopathy
- The topographic distribution of the first sites of diabetic retinal neovascularization.
- Topographical distribution of retinal and optic disc neovascularization in early stages of proliferative diabetic retinopathy.
- Origin of disc new vessels assessed by videofluorography.
- Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial
- Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
- Retinal Nonperfusion in the Posterior Pole Is Associated With Increased Risk of Neovascularization in Central Retinal Vein Occlusion.
- Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy
- Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial
- Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
- Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.
- Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
Cited by
- Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
- Pharmacotherapy and Nutritional Supplements for Neovascular Eye Diseases
- Regression Patterns of Neovascularization in Proliferative Diabetic Retinopathy Following Panretinal Photocoagulation - A Prospective, Observational Study
Related papers
No related papers recorded.